Laronidase Completed Phase 2 Trials for Mucopolysaccharidosis V / Type 1 Mucopolysaccharidosis / Hurler-Scheie Syndrome / Hurlers Syndrome Treatment

Indications	Status	Purpose	Phase
DBCOND0008371 (Mucopolysaccharidosis V) DBCOND0020490 (Type 1 Mucopolysaccharidosis) DBCOND0031271 (Hurler-Scheie Syndrome) DBCOND0043682 (Hurlers Syndrome)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00146757	A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old	Laronidase (DB00090)